38 results
Page 2 of 2
6-K
EX-99.1
9gq7e13pc2cwiu3zd7bu
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-4.1
ufqjm72l b4bmftwqcv
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
6-K
EX-1.1
s9gs4tjnzaw
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
F-1/A
EX-4.4
rwd4s98b
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-1.1
8oxr9dzkmbd25cn
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
6-K
EX-99.1
qcfrhutu
23 Jun 20
Annual and Special General Meeting of Shareholders
9:06am
424B4
pyaxuxb2n kzl
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
oumly6 cv30hmzt1
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
elimcv5hbvjkxak8bwlh
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
ad1t62xf
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
i78oz9j6e bvki1q1
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
6-K
EX-99.1
vvkcoitrwp x3657tx13
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
6-K
EX-99.1
lxy fe5g05ctpz0m0q4
6 Dec 18
Therapix Biosciences Reports Third
6:18am
6-K
EX-10.3
s3q 49bt9ma44gi
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
EX-99.1
wmzs7kgch5q 2is
6 Jun 18
Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update
4:55pm
20-F
kjeoi99o2jdwj pys
1 May 17
Annual report (foreign)
12:00am